
|Articles|August 1, 2008
The American Journal of Managed Care
- August 2008
- Volume 14
- Issue 8
Participant Disclosure (Am J Manag Care. 2008;14[suppl 8]:S241-S268)
Advertisement
Our July 2008 supplement on Biologics and Benefit Design, funded by Amgen Inc, (Am J Manag Care. 2008;14[suppl 8]:S241-S268), included an error of omission on the Participant Disclosures page.
The following disclosures for Robert Berglund should have been noted on S244:
Robert Berglund
Honoraria, Amgen Inc
Articles in this issue
over 17 years ago
A Meta-analysis Update: Percutaneous Coronary Interventionsover 17 years ago
Medicare HMO Impact on Utilization at the End of Lifeover 17 years ago
Flunking Asthma? When HEDIS Takes the ACTNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Emerging Breakthroughs in Neurodegenerative Disease Treatments: Kavita Nair, PhD, FAAN
3
Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL
4
New Proteomic Analysis Maps Cytokine Signatures Driving IPF
5















































